- Report
- October 2025
- 87 Pages
United States
From €4137EUR$4,500USD£3,517GBP
- Report
- October 2025
- 98 Pages
Middle East
From €4137EUR$4,500USD£3,517GBP
- Report
- August 2019
- 264 Pages
Global
From €3672EUR$3,995USD£3,122GBP
- Report
- December 2024
- 332 Pages
Global
From €3858EUR$4,197USD£3,280GBP
- Report
- September 2023
- 249 Pages
Global
From €4809EUR$5,414USD£3,950GBP
- Report
- February 2025
- 315 Pages
Global
From €4411EUR$4,799USD£3,751GBP
- Report
- January 2025
- 363 Pages
Global
From €4411EUR$4,799USD£3,751GBP
- Report
- April 2022
- 116 Pages
Global
From €1194EUR$1,299USD£1,015GBP
- Report
- October 2021
- 145 Pages
Global
From €4411EUR$4,799USD£3,751GBP
- Report
- October 2024
- 295 Pages
Global
From €1339EUR$1,508USD£1,100GBP
- Report
- April 2024
- 305 Pages
Global
From €5295EUR$5,962USD£4,350GBP
- Report
- December 2022
- 437 Pages
Global
From €4809EUR$5,414USD£3,950GBP
- Report
- October 2026
Global
From €750EUR$874USD£660GBP
- Report
- October 2026
Global
From €600EUR$699USD£528GBP
- Report
- October 2026
Global
From €600EUR$699USD£528GBP
- Report
- October 2026
Global
From €450EUR$524USD£396GBP
- Report
- October 2026
Global
From €450EUR$524USD£396GBP
- Report
- October 2026
Global
From €450EUR$524USD£396GBP
- Report
- October 2026
Global
From €450EUR$524USD£396GBP
- Report
- October 2026
Global
From €300EUR$350USD£264GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more